<DOC>
	<DOCNO>NCT00604409</DOCNO>
	<brief_summary>This trial test safety combine oral chemotherapy drug capecitabine radio-labeled microspheres inject directly liver .</brief_summary>
	<brief_title>Study Capecitabine Combination With SIR-Spheres Patients With Advanced Cancer</brief_title>
	<detailed_description>Patients adequate liver function performance status liver-directed therapy capecitabine would appropriate eligible clinical trial .</detailed_description>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>Adequate liver function Adequate performance status Significant extrahepatic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>